The Daily Beast

Big Pharma Doles Out Cash to Key Dems With Laser Precision

Jerod Harris/Getty Images for Protect Our Care

By Victoria Knight, Rachana Pradhan and Elizabeth Lucas at Kaiser Health News

The Biden administration and Congress are embroiled in high-stakes haggling over what urgent priorities will make it into the ever-shrinking social spending bill. But for the pharmaceutical industry there is one agenda: Heading off Medicare drug price negotiation, which it considers an existential threat to its business model.

The siren call to contain rising drug costs helped catapult Democrats to power, and the idea is popular among voters regardless of their politics. Yet granting Medicare broad authority to intervene in setting prices has nonetheless divided the party.

Read more at The Daily Beast.


About the author


Leave a Comment